title: Temsirolimus, interferon alfa or both in advanced renal-cell carcinoma: One plus one does not always equal two.
authors.affiliation: Department of Urology, Christian Medical College, Vellore, India. E-mail: chandrasingh@cmcvellore.ac.in.
authors.forename: S
authors.initials: S
authors.lastname: Grover
authors.forename: J C
authors.initials: JC
authors.lastname: Singh
authors.forename: N S
authors.initials: NS
authors.lastname: Kekre